Szeto, Christopher

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM

Vaske, C. J., Benz, S. C., Sanborn, J. Z., Earl, D., Szeto, C., Zhu, J., Haussler, D., & Stuart, J. M. (2010) · Bioinformatics

Bioinformatics and Genomic NetworksCancer Genomics and Diagnostics

Cited by 786

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Wong, G. S., Zhou, J., Liu, J. B., Wu, Z., Xu, X., Li, T., Xu, D., Schumacher, S. E., Puschhof, J., McFarland, J., et al. (2018) · Nature Medicine

Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling

Cited by 266

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses

Lineburg, K. E., Grant, E. J., Swaminathan, S., Chatzileontiadou, D. S. M., Szeto, C., Sloane, H., Panikkar, A., Raju, J., Crooks, P., Rehan, S., et al. (2021) · Immunity

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 183

Clinical trial screening of CDKN2A genomic alterations in patients with pancreatic cancer and hepatobiliary cancers requires greater precision than somatic sequencing alone.

Vaske, C. J., Garner, C., Seery, T. E., Szeto, C., & Reddy, S. K. (2019) · Journal of Clinical Oncology

Cancer Genomics and DiagnosticsPancreatic and Hepatic Oncology Research

Cited by 1